 |
|
Collaborative Alliance Research Education (CARE) Initiative:
GI Pharmacy Care Model
James C. Eoff III, PharmD
Executive Associate Dean
University of Tennessee College of Pharmacy
Memphis, Tennessee |
 |
|
|
|
Presented by The University of Kentucky College of Pharmacy, in Collaboration with the American Gastroenterological Association (AGA), and developed through a strategic educational facilitation by Gullapalli and Associates, LLC
|
|
|
| OVERVIEW: This educational initiative utilizes a multifocal educational approach, featuring an integrated series of interventions for participants to access a variety of formats, tools, and best practices guidelines specific to interacting with patients with gastrointestional (GI) disorders. Over a period of 12 months, participants will have access to multiple programs designed and developed to provide educational content in a practical format. |
|
|
|
 |
Collaborative Alliance Research Education (CARE) Initiative: GI Pharmacy Care Model is a multi-interventional educational program providing relevant and concise information about the pharmacy care model and its application to management of GI disorders prevalent in community practice environments based on a series of 3 regional meetings held in 2009. This initiative was designed to:
- Explain comorbidity and symptom overlap between irritable bowel syndrome with constipation (IBS-C), chronic constipation, gastroesophageal reflux disease (GERD), and clinical consequences of polypharmacy.
- Identify the role of the pharmacist in determining the appropriateness of selfcare or medical referral in the treatment of GI disorders (chronic constipation, GERD, IBS-C).
- Integrate pharmacy care strategies to educate, counsel, and monitor patients to optimize therapeutic outcomes associated with GI disorders (chronic constipation, GERD, IBS-C).
This monograph contributes to the blended learning of the overall initiative by providing a case-based review and integration of the key learnings captured during the live regional meetings of this initiative. The University of Kentucky College of Pharmacy takes responsibility for content, quality, and scientific integrity of this continuing educaton (CE) activity. Intended Audience: This activity is designed for community and institutional pharmacists who interact or are in the position to interact, with patients having GI motility concerns. |
|
|
|
|
How to Obtain Credit
1. Read monograph in its entirety.
2. Upon completion, go to www.CECentral.com/getcredit.
3. Enter activity code PEN10176.
4. Log in or register for a free
account.
5. Complete posttest and evaluation.
6. Get credit. A printable certificate
will be issued. |
The University of Kentucky College of Pharmacy is accredited  by the Accreditation Council for Pharmacy Education (ACPE) as a provider
of continuing pharmacy education. This knowledge-based activity has been assigned ACPE # 022-999-09-064-H04-P and will award up to 1.0 contact hour (0.1 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Statements of credit will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and posttest (score 70% or higher) and requesting credit online at conclusion of the activity. The College complies with the Accreditation Standards for Continuing Pharmacy Education. Start date: February 1, 2010. Expiration date: January 31, 2011.
|
|
|
|
| Disclosure of Financial Interest Summary |
|
In accordance with policies set forth by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), University of Kentucky UK HealthCare CECentral (UKHCCEC) requires all faculty members and spouses/significant others with an opportunity to affect the content of a continuing education activity to disclose any relevant financial relationships during the past 12 months with commercial interests. A commercial interest is any entity producing, marketing, re-selling or distributing health care goods or services consumed by or used on patients. Relationships with commercial interests and conflicts of interest resulting from those relationships must be revealed to the audience and resolved prior to the activity.
Relevant relationships include roles such as speaker, author, consultant, independent contractor (including research), employee, investor, advisory committee member, board member, review panelist, and investigator. If a potential speaker or author indicates a possible conflict of interest, the conflict will be resolved by choosing another speaker or author for that topical area, or the slides, handouts, and/or monograph will be reviewed and approved by a qualified commercially-disinterested peer.
Disclosure of a relationship is not intended to suggest or condone any bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. |
|
|
Faculty/Spouse/ Significant Other
|
No relevant financial relationships in past 12 months
|
Intend to discuss off-label use of a product
|
Commercial Interest
|
Role
|
Received
|
Conflict(s) resolved
|
|
James C. Eoff III, PharmD
|
None
|
No
|
None
|
Author/
faculty
|
Yes
|
N/A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inside the Issue
